StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO)

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued to investors on Monday morning. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

NASDAQ TTOO opened at $0.17 on Monday. The business has a fifty day simple moving average of $0.12 and a 200 day simple moving average of $0.33. T2 Biosystems has a 12 month low of $0.06 and a 12 month high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.